Short-term pedometer interventions produce significant health benefits several years later

Research which followed up two 12-week pedometer-based walking trials in adults showed long-term health benefits for the participants four years later.

Participants in the intervention groups in the PACE-UP and PACE-LIFT studies showed significantly fewer cardiovascular events, including heart attacks and strokes, as well as suffering fewer fractures, compared with those in the control groups in the studies.

St George’s team will help bring binx rapid point of care STI testing to patients

A team of scientists at St George’s are supporting the development of a new technology that could revolutionise sexual health treatment times in the UK.

Professor Tariq Sadiq and his team at the university’s Applied Diagnostic Research and Evaluation Unit (ADREU) have announced their support of the binx health io™ platform, with its chlamydia and gonorrhoea combined rapid test. The platform takes just about 30 minutes to give a result comparable to a central lab test, creating a first-of-its-kind ‘test and treat’ care model for these prevalent sexually transmitted infections.

Consortium wins EU grant to develop new leishmaniasis drug

Professor Sanjeev Krishna and colleagues are heading a consortium that has been awarded EUR3.75 million to develop a treatment for one of the world’s most neglected tropical diseases, leishmaniasis.

The funding is for full development of an exciting treatment prospect that has already shown promise in laboratory studies.

New measure shows antibiotics prescribed for children in hospitals around the world

A new measure has identified for the first time whether the most suitable antibiotics are being used to treat newborns and children in hospital on a national basis.  

The measure will be a crucial tool in combating antimicrobial resistance worldwide, allowing countries to benchmark themselves both internally and internationally and highlighting where improvements can be made.  

Spotlight on Science talk on 9 July: Immunotherapy - a new dawn in cancer treatment?

Immunotherapy is a revolutionary procedure that uses a patient’s own immune system to fight cancer. Trials have shown encouraging survival rates in patients and fewer side effects than traditional chemotherapy, including for the most aggressive of cancers.

But this ray of hope comes at a high price; since many treatments are bespoke, the costs involved are often prohibitive.

Immunotherapy - cancer cells